These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11272230)

  • 21. Transcatheter arterial embolization and extrabeam radiation therapy for subcutaneous seeding of hepatocellular carcinoma by percutaneous ethanol injection.
    Yamanaka T; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Takase K; Nakano T
    Hepatogastroenterology; 2002; 49(48):1656-8. PubMed ID: 12397757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma?
    Sherman M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):78-9. PubMed ID: 16456573
    [No Abstract]   [Full Text] [Related]  

  • 28. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oesophageal variceal bleeding in hepatocellular carcinoma with portal vein thrombosis: improved outcome in response to molecular target therapy.
    Wu SS; Yen HH; Chung CY
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):566-7. PubMed ID: 18555670
    [No Abstract]   [Full Text] [Related]  

  • 30. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Ann Surg Oncol; 2008 Jun; 15(6):1670-6. PubMed ID: 18368453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection.
    Andriulli A; De Sio I; Brunello F; Salmi A; Solmi L; Facciorusso D; Caturelli E; Perri F
    Aliment Pharmacol Ther; 2006 May; 23(9):1329-35. PubMed ID: 16629938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous ethanol injection under CT fluoroscopy for hypervascular hepatocellular carcinoma following transcatheter arterial embolization.
    Hamuro M; Kaminou T; Nakamura K; Matsuoka T; Sakai Y; Morimoto A; Hayashi S; Nakamura A; Hatagawa M; Yamada R
    Hepatogastroenterology; 2002; 49(45):752-7. PubMed ID: 12063984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhotic patient.
    de Sio I; Castellano L; Calandra M
    J Clin Ultrasound; 1992; 20(9):621-3. PubMed ID: 1331193
    [No Abstract]   [Full Text] [Related]  

  • 36. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system.
    Kielstein JT; Hesse G; Bahr MJ; Tsikas D; Terkamp C; Martens-Lobenhoffer J; Manns MP; Haller H; Panning B; Bode-Böger SM; Gebel M
    Crit Care Med; 2009 Apr; 37(4):1483-5. PubMed ID: 19242353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy.
    Petsas T; Kalogeropoulou C; Tsota I; Tsamandas AC
    Liver Int; 2006 Apr; 26(3):382-4. PubMed ID: 16584403
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.
    Yamamoto J; Okada S; Shimada K; Okusaka T; Yamasaki S; Ueno H; Kosuge T
    Hepatology; 2001 Oct; 34(4 Pt 1):707-13. PubMed ID: 11584366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma?
    Kadouchi K; Higuchi K; Shiba M; Okazaki H; Yamamori K; Sasaki E; Tominaga K; Watanabe T; Fujiwara Y; Oshitani N; Arakawa T
    J Gastroenterol Hepatol; 2007 Feb; 22(2):240-6. PubMed ID: 17295878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.